We are live on ! Find out more
SP

Sarasin & Partners Portfolio holdings

AUM $8.54B
1-Year Est. Return 9.6%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$7.15B
AUM Growth
+$134M
Cap. Flow
-$171M
Cap. Flow %
-2.39%
Top 10 Hldgs %
39.4%
Holding
139
New
7
Increased
31
Reduced
89
Closed
4

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$234M
2
VLO icon
Valero Energy
VLO
+$81.7M
3
TIF
Tiffany & Co.
TIF
+$53M
4
CXW icon
CoreCivic
CXW
+$42M
5
COST icon
Costco
COST
+$28.6M

Sector Composition

Rank Sector Weight
1 Financials 14.77%
2 Consumer Discretionary 13.82%
3 Communication Services 11.81%
4 Industrials 11.19%
5 Materials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOG icon
1
Alphabet (Google) Class C
GOOG
$4.19T
$342M 4.78%
11,825,318
+621,641
+6% +$16.9M
BWA icon
2
BorgWarner
BWA
$13B
$341M 4.77%
5,943,045
+464,494
+8% +$25.6M
JPM icon
3
JPMorgan Chase
JPM
$934B
$335M 4.69%
5,814,167
-19,103
-0.3% -$1.07M
HAL icon
4
Halliburton
HAL
$26.6B
$309M 4.32%
4,345,152
-367,155
-8% -$23.5M
HIG icon
5
Hartford Financial Services
HIG
$39.3B
$296M 4.14%
8,270,791
-8,952
-0.1% -$315K
AMGN icon
6
Amgen
AMGN
$207B
$290M 4.05%
2,446,276
+105,652
+5% +$12.2M
COST icon
7
Costco
COST
$420B
$237M 3.31%
2,056,447
-248,965
-11% -$28.6M
C icon
8
Citigroup
C
$224B
$235M 3.29%
4,995,947
-545,639
-10% -$26M
KMX icon
9
CarMax
KMX
$8.2B
$216M 3.03%
4,156,868
+60,898
+1% +$2.77M
CX icon
10
Cemex
CX
$17B
$215M 3.01%
18,292,526
+1,921,626
+12% +$21.8M
ADP icon
11
Automatic Data Processing
ADP
$105B
$210M 2.93%
3,010,494
+16,948
+0.6% +$1.16M
TV icon
12
Televisa
TV
$1.52B
$207M 2.9%
6,040,782
-137,730
-2% -$4.62M
ECL icon
13
Ecolab
ECL
$77.1B
$188M 2.62%
1,684,095
-43,543
-3% -$4.67M
SKM icon
14
SK Telecom
SKM
$12.1B
$169M 2.36%
3,946,587
-78,755
-2% -$3.07M
HOT
15
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$166M 2.32%
2,052,072
+26,889
+1% +$2.11M
BAP icon
16
Credicorp
BAP
$32.1B
$157M 2.2%
1,011,363
-18,025
-2% -$2.7M
VAR
17
DELISTED
Varian Medical Systems, Inc.
VAR
$150M 2.09%
2,052,502
-62,476
-3% -$4.49M
IP icon
18
International Paper
IP
$22.6B
$149M 2.08%
3,153,117
-356,781
-10% -$15.6M
IFF icon
19
International Flavors & Fragrances
IFF
$20.1B
$148M 2.07%
1,420,427
-171,874
-11% -$16.9M
RTX icon
20
RTX Corp
RTX
$288B
$145M 2.03%
2,001,145
+5,784
+0.3% +$426K
KSU
21
DELISTED
Kansas City Southern
KSU
$134M 1.88%
1,249,282
+212,749
+21% +$22M
CLR
22
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$129M 1.81%
1,637,202
-4,524
-0.3% -$314K
EMBJ
23
Embraer S.A. ADS
EMBJ
$12.2B
$127M 1.78%
3,499,200
+466,000
+15% +$16.5M
KMB icon
24
Kimberly-Clark
KMB
$36.2B
$127M 1.77%
1,186,579
+51,699
+5% +$5.49M
APC
25
DELISTED
Anadarko Petroleum
APC
$126M 1.76%
1,147,777
+1,089,196
+1,859% +$111M

Similar funds

Sarasin & Partners's Q2 2014 Portfolio in Review

As of Q2 2014, Sarasin & Partners held 139 positions worth $7.15B, up 1.9% from $7.01B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Sarasin & Partners's Q2 2014 filing shows 7 new, 31 increased, 89 reduced and 4 closed positions. Its largest new stake was Tata Motors Limited: 1,525,538 shares worth $59.6M. The largest sale was Pfizer, an estimated $234M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Sarasin & Partners's largest Q2 2014 buy was Tata Motors Limited: 1,525,538 shares worth $59.6M.
  • Sarasin & Partners added most to Anadarko Petroleum in Q2 2014, an estimated $111M increase.
  • Sarasin & Partners's biggest Q2 2014 reduction was Pfizer, cutting an estimated $234M.
  • Sarasin & Partners fully exited CATAMARAN CORP COM STK (CDA) in Q2 2014, selling an estimated $4.94M.
  • Sarasin & Partners's ten largest holdings make up 39% of its $7.15B portfolio in Q2 2014.
  • Sarasin & Partners opened 7 new positions and closed 4 in Q2 2014.
  • Sarasin & Partners's portfolio value rose 1.9% quarter-over-quarter to $7.15B.

Based on Sarasin & Partners's 13F filing for Q2 2014, filed 14 Jul 2014.